Comparative evaluation of combined and isolated applications of high-intensity focused ultrasound and super-selective uterine artery embolization in treatment of patients with uterine fibroids

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

BACKGROUND: Uterine fibroids are a benign tumor found in two out of three women of reproductive age. The most modern methods of organ preserving treatment of uterine fibroids are uterine artery embolization, which is a minimally invasive procedure, and high intensity focused ultrasound (HIFU) ablation, which is a non-invasive procedure. According to the literature and our own experience, uterine artery embolization is ineffective in 17.1% of cases and HIFU ablation in 16% of cases, mainly due to the peculiarities of blood supply to myomatous nodes.

AIM: The aim of this study was to compare the effectiveness of the treatment of uterine fibroids using an isolated HIFU ablation technique and combined sequential application of selective embolization of uterine artery supplying the myomatous node and HIFU ablation.

MATERIALS AND METHODS: This study included two groups of patients with symptomatic uterine fibroids. Group 1 consisted of 133 patients treated using the isolated HIFU ablation, and group 2 comprised 90 patients treated sequentially using supplying the myomatous node and HIFU ablation. Age and clinical manifestations of the disease (menometrorrhagia, pain syndrome, impaired function of adjacent organs, anemia) did not differ in the both groups.

RESULTS: The following parameters were different in the study groups: the duration of ultrasound ablation (p < 0.005) and the decrease in the volume of myomatous nodes in one, six and 12 months after surgery (p < 0.001). The duration of ultrasound ablation was 610.84 (56.26) minutes in group 1 and 215.28 (70.57) minutes in group 2. In group 1, the decrease in the volume of myomatous nodes was 12.2% in one month and 58.97% in 12 months after surgery, compared to the initial value. In group 2, the decrease was 42.9% and 67.5%, respectively.

CONCLUSIONS: The combined treatment of uterine fibroids using supplying the myomatous node and FUVI ablation techniques allowed for reducing the duration of the FUVI ablation operation three times and the volume of the node by 67.5% within one year compared to group 1 (58.97%).

Full Text

Restricted Access

About the authors

Alla K. Politova

National Medical and Surgical Center named after N.I. Pirogov

Email: al1870@mail.ru
ORCID iD: 0000-0002-5924-2616
SPIN-code: 6558-5394
Scopus Author ID: 535385

MD, Assistant Professor, Doctor of Medical Sciences, Head of the Women's Health Center, Professor of the Department of Women's Diseases and Reproductive Health

Russian Federation, 70, Nizhnyaya Pervomayskaya str., Moscow, 105203

Evgeny F. Kira

National Medical and Surgical Center named after N.I. Pirogov

Author for correspondence.
Email: profkira33@gmail.com
ORCID iD: 0000-0002-1376-7361
SPIN-code: 8955-9775
Scopus Author ID: 200738

MD, Doctor of Medical Sciences, Professor, Head of the Department of Women's Diseases and Reproductive Health

Russian Federation, 65, Nizhnyaya Pervomayskaya str., Moscow, 105203

Nikolay V. Bolomatov

National Medical and Surgical Center named after N.I. Pirogov

Email: n-v-bolomatov@yandex.ru
ORCID iD: 0000-0003-0590-2225
Scopus Author ID: 6506315445
ResearcherId: Z-5232-2019

MD, Doctor of Medical Sciences, Professor of the Department of Thoracic and Cardiovascular Surgery with the course of X-ray Endovascular Surgery

Russian Federation, 65, Nizhnyaya Pervomayskaya str., Moscow, 105203

Vycheslav M. Kitayev

National Medical and Surgical Center named after N.I. Pirogov

Email: vm_kitaev@list.ru
ORCID iD: 0000-0002-6093-5719
Scopus Author ID: 57193996795
ResearcherId: Z-5923-2019

MD, Doctor of Medical Sciences, Professor, Head of the Department of Radiation Diagnostics with the course of Clinical Radiology

Russian Federation, 65, Nizhnyaya Pervomayskaya str., Moscow, 105203

Sergey V. Bruslik

National Medical and Surgical Center named after N.I. Pirogov

Email: drbruslik@mail.ru
ORCID iD: 0000-0003-3865-3704

MD, Candidate of Medical Sciences, Head of the Department of Ultrasound and x-ray surgical methods Diagnostics and Treatment

Russian Federation, 70, Nizhnyaya Pervomayskaya str., Moscow, 105203

Tatyana I. Sviridova

National Medical and Surgical Center named after N.I. Pirogov

Email: drsviridova@mail.ru
ORCID iD: 0000-0002-2984-9505

MD, candidate of Medical Sciences, doctor of ultrasound of the Department of Ultrasound and x-ray surgical methods Diagnostics and Treatment

Russian Federation, 70, Nizhnyaya Pervomayskaya str., Moscow, 105203

Ekaterina A. Slabozhankina

National Medical and Surgical Center named after N.I. Pirogov

Email: elfkat@mail.ru
ORCID iD: 0000-0003-3816-293X
SPIN-code: 1615-5661

MD, candidate of Medical Sciences, doctor of ultrasound of the Department of Ultrasound and x-ray surgical methods Diagnostics and Treatment

Russian Federation, 70, Nizhnyaya Pervomayskaya str., Moscow, 105203

Yulia L. Amelina

National Medical and Surgical Center named after N.I. Pirogov

Email: doctoramelina@mail.ru
ORCID iD: 0000-0001-9903-4216
SPIN-code: 3528-5618

MD, postgraduate student of the Department of Women's Diseases and Reproductive Health

Russian Federation, 65, Nizhnyaya Pervomayskaya str., Moscow, 105203

Alexandra A. Politova

National Medical and Surgical Center named after N.I. Pirogov

Email: alexandra.politowa@mail.ru
ORCID iD: 0000-0002-2639-9043
Scopus Author ID: 57205459017

6th year student

Russian Federation, Moscow

References

  1. Buianova SN, Mgeliashvili MV, Petrakova SA. Current views of the etiology, pathogenesis, and morphogenesis of uterine myoma. Rossijskij vestnik akushera-ginekologa. 2008;8(6):45−51. (In Russ.)
  2. Radzinskij VE, Totchiev GF. Mioma matki: kurs na organosohranenie: informacionnyj bjulleten’. Moscow: StatusPraesens; 2014. (In Russ.)
  3. Mioma matki. Ed. by I.S. Sidorova. Moscow: MIA; 2003. (In Russ.)
  4. Vilos GA, Allaire C, Laberge PY, Leyland N. The management of uterine leiomyomas. J Obstet Gynaecol Can. 2015;37(2):157−178. doi: 10.1016/S1701-2163(15)30338-8
  5. Breusenko VG, Dobrohotova JuJe, Krasnova IA, et al. Jembolizacija matochnyh arterij: sovremennyj vzgljad na problemu. Chast’ II: metodicheskie aspekty. Diagnosticheskaja i intervencionnaja radiologija. 2007;1(2):56−70. (In Russ.)
  6. Kapranov SA, Breusenko VG, Dobrohotova JuJe, et al. Jembolizacija matochnyh arterij: sovremennyj vzgljad na problemu. Chast’ I: obshhie voprosy. Diagnosticheskaja i intervencionnaja radiologija. 2007;1(1):72−87. (In Russ.)
  7. Dobrohotova JuJe, Kapranov SA, Alieva AA, et al. Novyj organosohranjajushhij metod lechenija miomy matki − jembolizacija matochnyh arterij. Lechebnoe delo. 2005;(2):24−27. (In Russ.)
  8. Lubnin DM. Selektivnaja jembolizacija matochnyh arterij v algoritme organosohranjajushhego lechenija miomy matki [dissertation abstract]. Moscow; 2005. (In Russ). [cited 20 Sept 2021] Available from: https://www.dissercat.com/content/selektivnaya-embolizatsiya-matochnykh-arterii-v-algoritme-organosokhranyayushchego-lecheniya
  9. Nazarenko GI, Chen VSh, Dzhan L, Hitrova AN. Ul’trazvukovaja ablacija (HIFU) – vysokotehnologichnaja organosohranjajushhaja al’ternativa hirurgicheskogo lechenija opuholej. Moscow; 2008.
  10. Lyon PC, Rai V, Price N, et al. Ultrasound-guided high intensity focused ultrasound ablation for symptomatic uterine fibroids: Preliminary clinical experience. Ultraschall Med. 2020;41(5):550−556. (In German). doi: 10.1055/a-0891-0729
  11. Borah BJ, Yao X, Laughlin-Tommaso SK, et al. Comparative effectiveness of uterine leiomyoma procedures using a large insurance claims database. Obstet Gynecol. 2017;130(5):1047−1056. doi: 10.1097/AOG.0000000000002331
  12. Panagiotopoulou N, Nethra S, Karavolos S, et al. Uterine-sparing minimally invasive interventions in women with uterine fibroids: a systematic review and indirect treatment comparison meta-analysis. Acta Obstet Gynecol Scand. 2014;93(9):858−867. doi: 10.1111/aogs.12441

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2022 Eсо-Vector



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 66759 от 08.08.2016 г. 
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия Эл № 77 - 6389
от 15.07.2002 г.



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies